| Pharmaceutical Information |
| Drug Name |
Eslicarbazepine |
| Drug ID |
BADD_D00811 |
| Description |
Adjunctive Therapy for Adults with Partial-Onset Seizures |
| Indications and Usage |
Not Available |
| Marketing Status |
Not Available |
| ATC Code |
N03AF04 |
| DrugBank ID |
DB14575
|
| KEGG ID |
D09215
|
| MeSH ID |
C571001
|
| PubChem ID |
9881504
|
| TTD Drug ID |
D04QZD
|
| NDC Product Code |
Not Available |
| Synonyms |
eslicarbazepine | (10S)-10-hydroxy-10,11-dihydro-5H-dibenzo(b,f)azepin-5-carboxamide |
|
| Chemical Information |
| Molecular Formula |
C15H14N2O2 |
| CAS Registry Number |
104746-04-5 |
| SMILES |
C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
